Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and sta ...
…
continue reading
1
Your Stories: Conquering Cancer
Conquer Cancer, the ASCO Foundation | The American Society of Clinical Onco
Your Stories features candid conversations between patients, the people who love them, and the researchers looking for new treatments each day.
…
continue reading
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care professionals. Learn more about our award-winning journal!
…
continue reading
Outspoken Oncology, hosted by Chadi Nabhan, MD, MBA, FACP, is dedicated to facilitating candid discussion among all stakeholders on the most pressing—and often controversial—topics in cancer care today.
…
continue reading
The Cardiovascular CME podcast is a new educational offering from Mayo Clinic, featuring content geared towards physicians, physician assistants, and nurse practitioners who are interested in exploring a multitude of cardiology-related topics. Tune in and subscribe to explore today’s most pressing cardiology topics with your colleagues at Mayo Clinic and gain valuable insights that can be directly applied to your practice. No CME credit offered for podcast episodes at this time.
…
continue reading
In collaboration with Audio Journal of Oncology, OT now features audio-reports and interviews about new clinical research from major cancer meetings and key journals. The programs are created by the leading medical audioservice worldwide, Audio Medica, whose Audio Journal of Oncology has been bringing these lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are: George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVi ...
…
continue reading
AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets t ...
…
continue reading
…
continue reading
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on ...
…
continue reading
Welcome to TheOncoPT Podcast, where you'll learn how to be a confident, competent oncology physical therapist from oncology experts, practitioners, & patients.
…
continue reading
Healthy Conversations brings together leaders and innovators in health care to talk about the biggest issues facing patients and providers today. Every month, we explore new topics to help uncover the clinical insights and emerging technologies transforming health care in real time.
…
continue reading
A top podcast for healthcare leaders, with over one million downloads, Radio Advisory is your weekly download on how to untangle the industry's most pressing challenges to help leaders like you make the best business decisions for your organization. From unpacking major trends in care delivery—like site-of-care shifts and the rise of high-cost drugs—to demystifying stakeholder dynamics, to shining a spotlight on priorities that may get overlooked, we're here to help. Our hosts and seasoned r ...
…
continue reading
Nurse Papa is a podcast from the heart and mind of a pediatric oncology nurse and father. In each episode, I take a deep dive into a story of parenthood OR I answer a letter from a loyal parent listener about their most pressing parenting problems, in a segment called Dear Nurse Papa. In either case, I hope to come out on the other side with a greater understanding of what makes kids AND their parents tick.
…
continue reading
This book and subsequent audio companion reflect what I would have wanted when I was studying for the USMLE Step 2 CK exam. One of the major hurdles I faced while studying for my exam was the lack of a single reference resource similar to what existed for the USMLE Step 1 exam at the time of writing this book. This meant I had to use multiple resources which presented information in different formats and with different points of emphasis, resulting in a disorganized study approach. Despite m ...
…
continue reading
In a world overburdened with chronic disease, poor mental health and limited alternatives to conventional care more and more patients are looking for new solutions. Conventional medicine as we know it saves lives daily and is needed. However, alternative modalities are needed to help balance the current needs in the healthcare model. Today 48.6% of Americans are on at least one medication. In 2020 our life expectancy in the United States actually declined a year and a half. Clearly, we are n ...
…
continue reading
Together with prominent Pharmaceutical industry leaders, Impetus Digital is covering topics around what it means to be an effective leader in Pharma today. We are also exploring topics related to digital transformation, patient-centricity, industry partnerships, customer engagement, diversity in Pharma, systems thinking, current healthcare challenges, environmental and supply chain concerns, and the myriad of ways that Pharma is working to collectively and positively disrupt healthcare. At I ...
…
continue reading
A show where we rally some of our Nation's Greatest Nursing Leaders, Educators, Experts and Advocates to tackle some of the Greatest Challenges that the Nursing Profession faces! So sit back, relax and learn that Nurses CAN DO ANYTHING!
…
continue reading
Frederick Health presents Coffee with Cookie: A Podcast Focused on Your Health & Happiness. Taking care of yourself, making healthy choices, and focusing on overall wellness can feel like a complex topic, but it doesn’t have to be. Join us as we take a deeper dive into the world of healthcare, disease prevention, wellness, and more. Brought to you by healthcare experts and providers that see patients right here in Frederick County. Frederick Health is simplifying the world of healthcare—beca ...
…
continue reading
1
Finish Line Focus: Completing Your Oncology Case Report on Time
37:29
37:29
Play later
Play later
Lists
Like
Liked
37:29
Send us a text With just a few weeks left until the September 30 deadline, it's officially crunch time for your ABPTS Oncology Case Report and Application! In this episode, we're going to break down how to strategically approach your writing and how to avoid the common pitfalls that can derail your progress. Plus, I’ll share some tips on budgeting …
…
continue reading
1
De-risking Drug Development | Episode 5: Expand the use and value of your product over time
34:38
34:38
Play later
Play later
Lists
Like
Liked
34:38
De-risking Drug Development is a five-part podcast series that explores the business-critical decisions that take place at each stage of the drug development process. We know that novel therapies often don’t meet their revenue expectations, but through informed decision-making, you can minimize risk and maximize the probability of commercial succes…
…
continue reading
1
De-risking Drug Development | Episode 4: Implement market launch strategy, pre-approval
33:53
33:53
Play later
Play later
Lists
Like
Liked
33:53
De-risking Drug Development is a five-part podcast series that explores the business-critical decisions that take place at each stage of the drug development process. We know that novel therapies often don’t meet their revenue expectations, but through informed decision-making, you can minimize risk and maximize the probability of commercial succes…
…
continue reading
1
E132 | Leveraging AI to Protect Human Vocal Authenticity
25:49
25:49
Play later
Play later
Lists
Like
Liked
25:49
This episode of AI for Pharma Growth features an interview with Noah Kjos, the Co-Founder and COO of DeepTrust, a company that offers an AI tool to authenticate whether an audio recording was generated by an AI voice or a human voice. Andree and Noah discuss the growing threat of deep fake audio scams and the importance of being able to verify the …
…
continue reading
1
Cardiac Amyloidosis: No Longer Rare and Untreatable!
23:48
23:48
Play later
Play later
Lists
Like
Liked
23:48
Cardiac Amyloidosis: No Longer Rare and Untreatable! Guest: Omar F. Abou Ezzeddine, M.D., M.S. Hosts: Malcolm R. Bell, M.D. Transthyretin amyloid cardiomyopathy (ATTR-CM), once considered rare, is more prevalent than previously thought. Diagnosing ATTR-CM is particularly important because there are now highly effective, specific therapies for ATTR-…
…
continue reading
1
223: What would it take for home-based care to take off? With Medically Home's Dr. Matt Richards
29:55
29:55
Play later
Play later
Lists
Like
Liked
29:55
In the midst of the COVID-19 pandemic, The Centers for Medicare & Medicaid services released the Acute Hospital Care at Home payment waiver. The action was expected to usher in a new era of home-based care. But while it’s certainly grown in recent years, frankly, that massive shift hasn’t happened. The question is, why? This week, host Abby Burns i…
…
continue reading
1
Proven Tips & Tools To Survive Your Oncology Specialty Certification Prep
50:39
50:39
Play later
Play later
Lists
Like
Liked
50:39
Send us a text Oncology specialization can feel like Fight Club - because nooooobody talks about it until you’re in it. So in this episode we’re busting open the doors & diving into the process of specialization with Dr. Tori Crook. Dr. Crook is a board certified clinical specialist in oncologic physical therapy & acute care oncology physical thera…
…
continue reading
1
E131 | Leveraging A Robotic Pill for Non-Invasive Access to the Body
30:35
30:35
Play later
Play later
Lists
Like
Liked
30:35
This episode of AI for Pharma Growth features an interview with Torrey Smith, the Co-Founder and CEO of Endiatx, a company developing a revolutionary robotic pill that can provide a non-invasive way to observe inside the human body. Torrey explains the journey of Endiatx, progressing from a startup in a Silicon Valley garage to clinical trials and …
…
continue reading
1
IV Agents to Improve Echo Images, Value, and Safe Administration
24:45
24:45
Play later
Play later
Lists
Like
Liked
24:45
IV Agents to Improve Echo Images, Value, and Safe Administration Guest: Jeremy Thaden, M.D. Guest: Mays Ali, M.D. Hosts: Kyle Klarich, M.D. In this podcast we will review current and evolving indications for UEA use in the clinical and research setting. They will review Mayo Clinic’s practice for UEA administration, commonly encountered UEA side-ef…
…
continue reading
1
Picking Up the Pieces After Childhood Cancer
25:41
25:41
Play later
Play later
Lists
Like
Liked
25:41
Prom. Graduation. College. These are just a few rites of passage that high school seniors everywhere look forward to. But for Auburn, a devastating turn of events tilted her entire world off its axis and put all her senior year plans on hold. At just 18 years old, she was diagnosed with Hodgkin lymphoma, a type of blood cancer. Instead of graduatin…
…
continue reading
1
[Encore] What the industry is (still) getting wrong about value-based care
27:25
27:25
Play later
Play later
Lists
Like
Liked
27:25
(This episode originally aired on September 26, 2023.) Value-based care has been dominating industry conversations in recent years. Here on Radio Advisory, we talk a lot about best practices, how to make the right investments, and how to best prepare leaders for the future of value-based care. But given all this momentum, we want to spend time aski…
…
continue reading
This episode features an interview with Marco Baldocchi, the founder and CEO of the Marco Baldocchi Group, who specialises in leveraging AI in neuromarketing. Marco discusses his background in marketing and economics, and how a personal experience with buying a car led him to explore the unconscious decision-making processes of consumers. Marco exp…
…
continue reading
1
Cardioneural Ablation - A Promising Treatment Strategy for Refractory Vasovagal Syncope
11:54
11:54
Play later
Play later
Lists
Like
Liked
11:54
Cardioneural Ablation - A Promising Treatment Strategy for Refractory Vasovagal Syncope Guest: Guru G. Kowlgi, M.B.B.S. Host: Anthony H. Kashou, M.D. The learners will get an overview of how to diagnose and manage vasovagal syncope. In addition, they will gain an understanding of cardioneural ablation, which is a promising new catheter ablation tre…
…
continue reading
1
222: It's not just GLP-1s; here's what comprehensive weight management looks like
25:45
25:45
Play later
Play later
Lists
Like
Liked
25:45
In the last few years, all eyes have turned to GLP-1s as an industry-altering answer to obesity treatment and weight management. But the fact is, these drugs can’t – and shouldn’t – work in a vacuum. There is a fear that attention on GLP-1s may even blind leaders to the other services that go into providing effective obesity care. So, what should l…
…
continue reading
1
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
17:15
17:15
Play later
Play later
Lists
Like
Liked
17:15
Interview with Eileen M. O’Reilly, MD, author of Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer. Hosted by Vivek Subbiah, MD. Related Content: Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
…
continue reading
1
E129 | Leveraging Wastewater and AI to Predict Population Health Threats
22:23
22:23
Play later
Play later
Lists
Like
Liked
22:23
In this episode, Dr. Andree Bates speaks to Mariana Matus, the co-founder and CEO of Biobot, a company that is transforming wastewater infrastructure into public health observatories. Mariana explains the concept of wastewater epidemiology, where wastewater samples from communities are collected and analysed for various disease indicators, includin…
…
continue reading
1
Pre-Pregnancy Risk Assessment for CV Patients
15:20
15:20
Play later
Play later
Lists
Like
Liked
15:20
Pre-Pregnancy Risk Assessment for CV Patients Guest: Katie A. Young, M.D. Hosts: Malcolm R. Bell, M.D. In this podcast we will review the importance of specialized care in Cardiovascular Obstetrics and the role of the Pregnancy Heart Team in pregnancy risk assessment and pre-conception counseling. Topics Discussed: With maternal mortality rates bei…
…
continue reading
1
221: How will health system growth look different in 2025 and beyond?
25:12
25:12
Play later
Play later
Lists
Like
Liked
25:12
When we talk about “health systems,” it can sound like we’re talking about a monolith. But in reality, the $1.4 trillion dollar health system sector is made up of a diverse range of players. Academics and safety nets; urban and rural systems; 1,000-bed systems and 25-bed critical access hospitals. The question is, especially as systems emerge from …
…
continue reading
1
Identification of Immune Checkpoint Inhibitor–Induced Diabetes
14:36
14:36
Play later
Play later
Lists
Like
Liked
14:36
Interview with Michelle Rengarajan, MD, PhD, author of Identification of Immune Checkpoint Inhibitor–Induced Diabetes. Hosted by Vivek Subbiah, MD. Related Content: Identification of Immune Checkpoint Inhibitor–Induced Diabetes
…
continue reading
1
E128 | Leveraging AI for Early Disease Prediction
32:11
32:11
Play later
Play later
Lists
Like
Liked
32:11
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Xander Kerman Gregory, the Head of Growth at Ubie Health, to discuss the company's innovative work in early disease prediction through the power of artificial intelligence. Ubie Health focussed on user-centric design to dynamically guide patients through a series of carefully se…
…
continue reading
1
Cardio-oncology: What is the Big Picture, What Drugs to Use, and What Tests to Follow
27:47
27:47
Play later
Play later
Lists
Like
Liked
27:47
Cardio-oncology: What is the Big Picture, What Drugs to Use, and What Tests to Follow Guest: Chadi Ayoub, M.B.B.S., Ph.D. Hosts: Sharonne N. Hayes, M.D. In this podcast, we will describe more frequent cardiotoxic effects associated with cancer therapies. Identify imaging modalities that can be used to detect and evaluate cardiotoxicity and common a…
…
continue reading
1
220: Why AI in healthcare is more than just ChatGPT
26:04
26:04
Play later
Play later
Lists
Like
Liked
26:04
We’ve talked a lot about AI on Radio Advisory, with a particular emphasis on generative models and their capabilities. But are there other models of AI that are flying under the radar? Today’s episode focuses on computer vision and its potential to shift how we think about the use of technology in healthcare. For the second episode in our series le…
…
continue reading
1
Chapter 10: Rheumatology - Crystalline Arthropathy
5:55
5:55
Play later
Play later
Lists
Like
Liked
5:55
A brief discussion of gout, pseudogout, and synovial fluid analysis.By Abdillahi Omar, M.D.
…
continue reading
1
E127 | Who is using your face? Find out with AI
26:56
26:56
Play later
Play later
Lists
Like
Liked
26:56
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by IdentifAI founders Justin Marciano and Paul Vann to explore the deep fake challenge and the innovative solutions they are developing. The pair share their unique backgrounds and motivations for founding the company, emphasising the critical need to address the growing threat of …
…
continue reading
1
10 Years of Prospective Surveillance Model: Why Aren't We Further Along? (Replay)
1:23:35
1:23:35
Play later
Play later
Lists
Like
Liked
1:23:35
Send us a text It's been 12 years since the Prospective Surveillance Model was first published. This model saves our patients money, can prevent functional decline, & has changed our entire paradigm of how we treat people with cancer. So why is it still so rare to see it implemented? Buckle up, OncoPT, because there’s a lot to cover today. But it’s…
…
continue reading
1
Clinical Quantification of Myocardial Blood Flow Using PET
21:03
21:03
Play later
Play later
Lists
Like
Liked
21:03
Clinical Quantification of Myocardial Blood Flow Using PET Guest: Panithaya Chareonthaitawee, M.D. Hosts: Malcolm R. Bell, M.D. In this podcast, we will describe the clinical applications of PET MBF quantitation and discuss the strengths and limitations of PET MBF quantification. Topics Discussed: Why has PET myocardial perfusion imaging seen such …
…
continue reading
Gabriele “Gabe” Grunewald was a professional distance runner and a relentless optimist. She competed in Big Ten Championship races, became an NCAA track and field All-American athlete, and finished 4th in the 2012 U.S. Olympic Trials. Such accomplishments become even more impressive when you learn that—even as she racked up accolades and wins—Gabe …
…
continue reading
It's no secret that climate change has had a massive effect on population health, but it’s also impacting healthcare business. Did you know that energy costs have gone up by 28% in the past five years? Health systems in particular can shave percentage points off their annual costs by reducing their energy consumption—but there is both a knowledge g…
…
continue reading
1
Chapter 10: Rheumatology - Seronegative Spondyloarthropathies
6:55
6:55
Play later
Play later
Lists
Like
Liked
6:55
Review of seronegative spondyloarthropathies.By Abdillahi Omar, M.D.
…
continue reading
1
Chapter 10: Rheumatology - Collagen Vascular Disease
28:20
28:20
Play later
Play later
Lists
Like
Liked
28:20
Extensive review of all things related to collagen vascular and autoimmune disease.By Abdillahi Omar, M.D.
…
continue reading
1
Chapter 9: Hematology-Oncology - Miscellaneous Oncology
12:03
12:03
Play later
Play later
Lists
Like
Liked
12:03
We conclude this chapter discussing oncologic syndromes, paraneoplastic associations, and review of screening guidelines.By Abdillahi Omar, M.D.
…
continue reading
1
E126 | The impact of RAG and LLMs on data processing and decision-making
25:51
25:51
Play later
Play later
Lists
Like
Liked
25:51
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Vinoth Nageshwaran, a leading data engineer currently working at Business Insider. Vinoth discusses the challenges of large language models (LLMs) like ChatGPT, which often hallucinate or generate inaccurate information due to their lack of true understanding and ability to veri…
…
continue reading
1
3D Visualization of the Heart in Immersive Technology Like Mixed Reality
17:47
17:47
Play later
Play later
Lists
Like
Liked
17:47
3D Visualization of the Heart in Immersive Technology Like Mixed Reality Guest: Dr. Klaudia Proniewska Host: Anthony H. Kashou, M.D. The most commonly applied way of teaching students the foundations of human anatomy and physiology involves textbooks and lectures. This method of transmitting knowledge causes difficulties for students, especially in…
…
continue reading
1
Do These Things to Treat Your Patient with Bone Metastases Better (Replay)
38:18
38:18
Play later
Play later
Lists
Like
Liked
38:18
Send us a text If you ask any rehab professional what scares them the most about oncology patients, their answer 99.9% of the time will be bone metastases. And this fear is keeping rehab professionals from actually helping their patients with cancer (even those without bone mets). The fact is patients with bone metastases benefit from rehab, from e…
…
continue reading
1
218: [Encore + bonus content] Site-of-care shifts: It's time to go on offense
37:18
37:18
Play later
Play later
Lists
Like
Liked
37:18
This week, host Abby Burns invites Advisory Board expert Sebastian Beckmann back to Radio Advisory to provide an update—as promised—on what his team has uncovered about site-of-care shifts in the six months since he first brought this research to the pod. Hint: there’s about $50B at play. This episode is a modified encore of Episode 195: Site-of-ca…
…
continue reading
Reviewing the different subtypes of lymphoma and their associations.By Abdillahi Omar, M.D.
…
continue reading
1
Chapter 9: Hematology-Oncology - Plasma Cell Dyscrasias
6:00
6:00
Play later
Play later
Lists
Like
Liked
6:00
A discussion on plasma cell dyscrasias primarily focused on Multiple Myeloma and Waldenström’s Macroglobulinemia.By Abdillahi Omar, M.D.
…
continue reading
1
Chapter 9: Hematology-Oncology - Thrombocytosis
2:13
2:13
Play later
Play later
Lists
Like
Liked
2:13
A brief discussion on essential thrombocytosis and other causes of elevated platelet counts.By Abdillahi Omar, M.D.
…
continue reading
1
E125 | Using AI to power early detection and provide better treatments in oncology and cardiovascular care
23:20
23:20
Play later
Play later
Lists
Like
Liked
23:20
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Navid Alipour, CEO of CureMetrix, which is a leading AI-powered medical imaging company that specialises in early detection of breast cancer and heart disease. The company has received two historic FDA clearances for its AI-powered breast cancer detection and breast arterial cal…
…
continue reading
1
Chapter 9: Hematology-Oncology - White Blood Cell Dyscrasias
14:37
14:37
Play later
Play later
Lists
Like
Liked
14:37
We finally shift our attention to the oncology section, starting with a review of white blood cell dyscrasias.By Abdillahi Omar, M.D.
…
continue reading
1
Collaboration Catapults Your Patient Care - Here's How To Start
39:19
39:19
Play later
Play later
Lists
Like
Liked
39:19
Send us a text ICYMI: Katie Ledecky is 🐐 And while she’s been crushing it at #Paris2024, she’s also been serving up some lessons that cancer rehab NEEDS TO LEARN. In short, you can’t practice in a silo & realistically expect to see improved patient care. What you need instead is COMMUNITY. Learn how sharing knowledge, providing support, leading by …
…
continue reading
Marfan Surgery Guest: Alberto Pochettino, M.D. Hosts: Paul A. Friedman, M.D. Marfan syndrome is a genetic abnormality where the fibrillin protein is abnormal. That affects all collagen structures within a given individual. Phenotypic features involve ocular abnormalities such as lens dislocation and a higher risk of retinal detachment, as well as d…
…
continue reading
1
[Encore] Test, fail, and test again: Morgan Health's approach to employer costs
38:54
38:54
Play later
Play later
Lists
Like
Liked
38:54
(This episode originally aired on September 12, 2023.) With rising costs and tightening margins, the industry is continually looking for ways to "bend the cost curve" while maintaining, or even increasing, quality and performance. One stakeholder in particular, employers, are feeling significant pressures from inflation, hospital consolidation, the…
…
continue reading
1
Podcast: Accelerated approvals – what’s next, confirmatory trials, access, and pricing
12:51
12:51
Play later
Play later
Lists
Like
Liked
12:51
Focusing on cell and gene therapies, this podcast discusses the use of accelerated approvals for fast tracking promising novel medicines through clinical development to registration.By PAREXEL
…
continue reading
1
Chapter 9: Hematology-Oncology - Clotting Disorders
22:03
22:03
Play later
Play later
Lists
Like
Liked
22:03
A thorough discussion on acquired and congenital clotting disorders, and a review of anticoagulant pharmacology.By Abdillahi Omar, M.D.
…
continue reading
1
Chapter 9: Hematology-Oncology - Bleeding Disorders
17:46
17:46
Play later
Play later
Lists
Like
Liked
17:46
Review of primary and secondary hemostasis, followed by a breakdown bleeding disorders based on congenital, acquired, function, and quantitative causes.By Abdillahi Omar, M.D.
…
continue reading
1
E124 | How AI is being used to tackle global health challenges
29:58
29:58
Play later
Play later
Lists
Like
Liked
29:58
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Julien Willard, a Partner and Life Science Lead at IBM. Julien is focused on how AI is being used to tackle global health challenges, particularly in low and middle-income countries (LMICs). Julien & Andree discuss the importance of accounting for local context when implementing…
…
continue reading
1
{Research Round-Up} Leveraging Social Media to Improve Access for AYA Survivors
49:49
49:49
Play later
Play later
Lists
Like
Liked
49:49
Send us a text In this first edition of our special Research Round-Up series, we dive into groundbreaking research that examines a novel way to put adolescent & young adult (AYA) survivors BACK in the driver’s seat of their care. Dr. Kelly Martin, physical therapist & TheOncoPT team member, joins Elise to discuss the importance of education and bri…
…
continue reading
1
Hypertensive Disorders of Pregnancy and CV Risk
19:41
19:41
Play later
Play later
Lists
Like
Liked
19:41
Hypertensive Disorders of Pregnancy and CV Risk Guest: Thais D. Coutinho, M.D. Hosts: Paul A. Friedman, M.D. Hypertensive disorders of pregnancy are common and are associated with a significant increase in the risk of future cardiovascular diseases. Despite the well-established statistics, this increase in risk is not well recognized by patients or…
…
continue reading
1
[Encore] Why can't providers and plans just get along?
31:10
31:10
Play later
Play later
Lists
Like
Liked
31:10
(This episode originally aired on March 12, 2024.) The relationship between health plans and providers has always included an element of friction, but lately, it seems like the temperature is rising. And you've probably noticed – public contracting disputes increased by 69% between 2022 and 2023. That's why, in this episode, host Abby Burns invites…
…
continue reading